龈下牙周治疗对2型糖尿病患者血糖控制的影响:6个月随访随机临床试验的Meta分析与Meta回归
结果显示龈下器械治疗较非积极治疗使HbA1c降低0.29%(95%CI 0.10-0.47;p=.03),证据等级为中等。
要点
- 龈下器械治疗可使2型糖尿病合并牙周炎患者6个月时HbA1c降低0.29%。
- 该降幅具有统计学显著性和临床相关性,证据等级为中等。
- 12项研究均未被评估为低偏倚风险,异质性部分由女性比例和糖尿病确诊时间解释。
核心结论
- 龈下牙周治疗在6个月内对2型糖尿病合并牙周炎患者的血糖控制产生显著且具有临床相关性的改善。
研究设计与样本
- 检索9个电子数据库至2023年2月15日,纳入12项至少随访6个月的随机对照试验,排除使用全身或局部抗菌治疗的研究。
- 采用随机效应模型进行Meta分析,线性Meta回归评估异质性来源,RoB 2评估偏倚风险,GRADE评估证据确定性。
主要发现
- 龈下器械治疗较非积极治疗使HbA1c降低0.29%(95%CI:0.10-0.47;p=.03)。
- 女性比例和糖尿病确诊时间显著解释了高异质性水平。
- 12项研究中无一被评估为低偏倚风险,证据等级为中等。
关键数值与推荐
- 龈下器械治疗(伴或不伴翻瓣)为牙周炎金标准治疗,较非积极治疗HbA1c降低0.29%(95%CI:0.10-0.47;p=.03)。
临床怎么用
- 对2型糖尿病合并牙周炎患者,龈下牙周治疗可作为改善血糖控制的辅助措施,6个月随访可见HbA1c降低0.29%。
局限性
- 纳入的12项研究均未被评估为低偏倚风险,证据确定性为中等。
- 异质性较高,部分由女性比例和糖尿病确诊时间解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periodontitis worsens the hyperglycaemia in patients with type 2 diabetes mellitus (T2DM). Subgingival instrumentation, with or without surgical access, is the gold-standard treatment for periodontitis. The aim was to summarize the evidence on the effect of subgingival instrumentation (with or without open flap) on the reduction of glycosylated haemoglobin (HbA1c). METHODS: Nine electronic databases were searched up to 15 February 2023. Twelve randomized controlled trials with at least 6 months of follow-up were included. Studies using systemic or local-delivery antimicrobial therapies were excluded. Meta-analyses were performed using the random-effects model. The sources of heterogeneity were assessed by applying linear meta-regression. Risk of bias was assessed by RoB 2, and certainty of evidence by GRADE. RESULTS: Eleven studies were included in the quantitative analyses (1374 patients). Subgingival instrumentation resulted in 0.29% lower HbA1c (95% confidence interval: 0.10-0.47; p = .03) compared with non-active treatment. DISCUSSION: None of the 12 studies were assessed as having low risk of bias. The percentage of females and the time of diabetes diagnosis significantly explained the high level of heterogeneity. Subgingival periodontal therapy results in a significant and clinically relevant improvement in glycaemic control over 6 months in patients with T2DM and periodontitis. The grade of evidence was moderate.
引用
- Oliveira VB, Costa FWG, Haas AN, et al. Effect of subgingival periodontal therapy on glycaemic control in type 2 diabetes patients: Meta-analysis and meta-regression of 6-month follow-up randomized clinical trials. J Clin Periodontol. 2023. PMID: 37257917. doi:10.1111/jcpe.13830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。